TABLE V. Correlation between isolates characterised as Sporothrix brasiliensis that presented or not intraspecific variation, with clinical and epidemiological variations of 47 cats assisted at the Laboratory of Clinical Research on Dermatozoonosis in Domestic Animals (INI)/Fiocruz, Rio de Janeiro - Brazil, 2010 to 2011.
Group I* | Group II** | |||
---|---|---|---|---|
Variables | n = 14 | n = 33 | p-value*** | |
General health | Good | 13 (92.9%) | 29 (87.9%) | 1 |
Regular | 1 (7.1%) | 4 (12.1%) | ||
Distribution of skin lesions | L1 | 5 (35.7%) | 10 (30.3%) | 0.478 |
L2 | 6 (42.9%) | 10 (30.3%) | ||
L3 | 3 (21.4%) | 13 (39.4%) | ||
Respiratory signs | Present | 10 (71.4%) | 17 (51.5 %) | 0.333 |
Absent | 4 (28.6%) | 16 (48.5%) | ||
Skin lesions | Present | 12 (85.7%) | 33 (100%) | - |
Absent | 2 (14.3%) | 0 | ||
Mucosal lesions | Present | 7 (50%) | 12 (36.4%) | 0.5181 |
Absent | 7 (50%) | 21 (63.6%) | ||
Lymphadenomegaly | Present | 14 (100%) | 28 (84.8%) | - |
Absent | 0 | 5 (15.2%) | ||
Retroviruses (FIV/FeLV) | Positive | 3 (21.4%) | 9 (27.3%) | 1 |
Negative | 11 (78.6%) | 24 (72.7%) | ||
Functional rhinitis | Present | 8 (57.1%) | 12 (36.4%) | 0. 214 |
Absent | 6 (42.9%) | 21 (63.6%) | ||
Outcome | Favorable (Cure) | 6 (42.9%) | 11 (33.3%) | 0.740 |
Unfavorable | 8 (57.1%) | 22 (66.7%) | ||
Castrated | Yes | 7 (50%) | 12 (36.4%) | 0.518 |
No | 7 (50%) | 21 (63.4%) | ||
Sex | Female | 4 (28.6%) | 8 (24.2%) | 0.731 |
Male | 10 (71.4%) | 25 (75.8%) |
isolates with intraspecific variation in molecular technique;
isolates without intraspecific variation in molecular technique;
p < 0.05.